Return to homepagePandemic Pact

Task A68: Screening Vaccine (and Other Biologics) Platform Technologies using Coronavirus Mouse Immunogenicity as a Model System

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 272201700036I-0-759302200001-1

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2022
    2023

  • Known Financial Commitments (USD)

    $563,541

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    RALPH BARIC

  • Research Location

    United States of America

  • Lead Research Institution

    UNIV OF NORTH CAROLINA CHAPEL HILL

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Disease models

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

This contract provides for the development and standardization of small animal models of infectious diseases, and may include efficacy testing of candidate products, including GLP studies to support licensure.